TD Cowen and Truist Financial raised their price targets for DaVita shares on August 8, 2026.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen and Truist Financial raised their price targets for DaVita shares on August 8, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
DaVita
renal dialysis center chain based in the United States
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- TD Cowen raised its price target on Exelixis shares on August 30, 2026.
- TD Cowen lowered its price target for Navan, Inc. stock on September 10, 2026.
- TD Cowen raised its price objective on Illumina stock on August 26, 2026.
- Truist Financial and TD Cowen raised target prices and issued buy ratings for Astrana Health, Inc. on June 10, 2026.
- Truist Financial boosted price target and gave buy rating, and TD Cowen lifted target price and gave buy rating for Encompass Health.